Relating to the prescription, administration, and possession of certain opioid antagonists for the treatment of suspected opioid overdoses, training about opioid antagonists and drug overdoses, and grants for related programs.
Impact
The legislation introduces significant changes to the existing laws by ensuring that individuals and organizations can possess and administer opioid antagonists without fear of legal repercussions. Pharmacists are also required to provide educational counseling on overdose recognition, prevention, and the proper use of opioid antagonists. These changes are meant to foster a culture of awareness and responsiveness towards opioid overdoses, ultimately aiming to reduce fatalities associated with overdoses in the state.
Summary
House Bill 2149 focuses on the prescription, administration, and possession of opioid antagonists, which are medications used to counteract opioid overdoses. The bill establishes clear guidelines allowing healthcare professionals to prescribe these lifesaving drugs to individuals at risk of opioid overdose, as well as to friends or family members who may assist those individuals. This provision aims to increase accessibility and readiness for potential overdose situations among the general public as well as emergency responders.
Contention
One notable point of contention surrounding HB 2149 is the balance between accessibility of life-saving medications and concerns around enabling substance use. Advocates argue that increasing access to opioid antagonists is a critical step towards combating the opioid crisis and saving lives. However, opponents may worry about the lack of mandated educational components or support systems accompanying the distribution of these medications, possibly leading to misuse or underutilization in critical situations.
Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.